Enfusion Inc
NYSE:ENFN

Watchlist Manager
Enfusion Inc Logo
Enfusion Inc
NYSE:ENFN
Watchlist
Price: 10.76 USD -0.37% Market Closed
Market Cap: 1.4B USD

Enfusion Inc
Investor Relations

Enfusion Inc. emerges as a notable player in the financial technology landscape, focusing on streamlining operations for investment managers through its cloud-native platform. Founded in Chicago, Enfusion began its journey to address the complexities faced by hedge funds and asset managers. By offering a cohesive suite of solutions, including portfolio management, order management, and accounting systems, Enfusion has carved a niche for itself. These integrated services enable clients to manage their entire investment lifecycle from a singular platform, eliminating the cumbersome need for multiple disconnected systems. This efficiency not only bolsters operational effectiveness but also offers significant cost savings, making Enfusion an attractive proposition for financial firms looking to modernize their back-office functions.

The company generates revenue through a scalable, subscription-based model. Clients pay for access to Enfusion's robust software platform and the array of offerings it includes. This model provides Enfusion with a steady, predictable income stream, while also allowing clients the flexibility to tailor solutions according to their specific needs and scale, as necessary, without incurring significant upfront costs. Adding to its appeal, Enfusion provides comprehensive customer support and continuous software updates, ensuring that clients always work with the most current tools. By prioritizing innovation and client-centric services, Enfusion not only retains its existing customers but also continually attracts new ones in an industry that values both technological advancement and operational efficiency.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2024
Call Date
Nov 4, 2024
Q3 2024 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Earnings Call Recording
Other Earnings Calls

Management

Mr. Bradley Herring
Chief Financial Officer
No Bio Available
Mr. Neal Pawar
Chief Operating Officer
No Bio Available
Mr. Stephen Malherbe
Managing Partner
No Bio Available
Ms. Valeria Gutowski
Chief Accounting Officer
No Bio Available
Mr. Daniel Groman
Chief Technology Officer
No Bio Available
Mr. Ignatius Tochukwu Njoku
Head of Investor Relations
No Bio Available
Ms. Bronwen Bastone
Chief People Officer
No Bio Available
Mr. Joseph Defeo
Global Head of Managed Services Production
No Bio Available
Mr. Jeff Young
Head of Implementation
No Bio Available
Mr. Robert Taylor
Head of Client Support
No Bio Available

Contacts

Address
ILLINOIS
Chicago
125 South Clark Street, Suite 750
Contacts
+13122539800.0
enfusion.com